Avalon Health Economics LLC (“AHE”) was formed by a group of experienced academic and industry health economists and associates, bringing together several existing consulting practices. The company’s origins were in the Health Economics Consulting Group LLC, which started in 2004. We provide high-quality, high-value real-world health economics consulting and research services relying on unparalleled industry […]
Latest Posted Listings
Boutique global consultancy and leaders in formulation of market access and pricing strategies, evidence generation and evidence synthesis, including outcomes research. Our global evidence based solutions cover retrospective charts reviews, surveys and observational cohort studies.We offer a deep scientific bench that collaborates cross-functionally to address client needs. MKTXS partners with clients for both the development […]
DDi is Clinical Development informatics – technologies and e clinical solutions provider for clinical development and Regulatory to Life sciences, Biotech and pharmaceutical Industries.Solutions include Clinical Analytics, Electronic Data Management, Clinical Supply Chain Management, Clinical Risk Based Management, Clinical RBM.
Policy Alerts was developed by industry professionals with extensive experience locating and monitoring medical policies for Medical Device, Pharmaceutical and Diagnostic companies. We work closely with customers to identify key words and search parameters that allow our proprietary software to quickly and accurately locate relevant information pertaining their products. Our software continuously searches a strategically […]
Not all recruiters are the same… I am an Independent Headhunter for HEOR, Market Access & Reimbursement professionals around the world and I am also one of the longest serving recruiters in the sector, having worked in this area since 2009. Working with me is quite different to working with a recruitment agency: As an […]
Healthcare is at a turning point. We have entered a new era of high patient expectations, aging populations and socioeconomic constraints. At the same time, attention is focusing more closely on personalized/precision medicine approaches to healthcare delivery, and healthcare options, especially in fields such as oncology, are proliferating. The use of real-world evidence and big […]